Barbara Kirschner to Anti-Inflammatory Agents
This is a "connection" page, showing publications Barbara Kirschner has written about Anti-Inflammatory Agents.
Connection Strength
0.910
-
Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease. J Pediatr Gastroenterol Nutr. 2007 Sep; 45(3):312-8.
Score: 0.242
-
Timing infliximab therapy in pediatric Crohn's disease. Gastroenterology. 2007 Mar; 132(3):1167-70.
Score: 0.234
-
Differences in the management of inflammatory bowel disease in children and adolescents compared to adults. Neth J Med. 1998 Dec; 53(6):S13-8.
Score: 0.132
-
Methotrexate therapy for pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 1998 May; 4(2):121-3.
Score: 0.127
-
Increased effectiveness of early therapy with anti-tumor necrosis factor-a vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014 Feb; 146(2):383-91.
Score: 0.093
-
Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab. J Pediatr Gastroenterol Nutr. 2012 Jan; 54(1):28-33.
Score: 0.082